Skip to main content
Fig. 3 | The Journal of Headache and Pain

Fig. 3

From: Real-world effectiveness and satisfaction with intravenous eptinezumab treatment in patients with chronic migraine: REVIEW, an observational, multi-site, US-based study

Fig. 3

Patient-reported satisfaction with eptinezumab’s ability to impact migraine symptoms

Percentages may not add up to 100% due to rounding. Patients were prompted: “Please rate how much you agree or disagree with the following statements by placing a checkmark ✓ in the column which most closely fits your opinion: I am satisfied with eptinezumab’s ability to…” Choices included: strongly agree, agree, neutral, disagree, and strongly disagree.

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us